The diagnosis of pulmonary diseases is a systematic process that combines various methods such as clinical observation, imaging examinations, and laboratory analyses. Physicians collect medical history, evaluate symptoms, and perform physical examinations to make an initial assessment of possible causes, then proceed with specialized tests based on suspected diagnoses. Early diagnosis not only improves treatment success rates but also effectively delays disease progression.
The diagnostic process typically begins with the patient's basic symptoms, such as long-term cough, difficulty breathing, or chest pain, including their nature and duration. Physicians further inquire about exposure history, such as smoking habits, occupational environment, or family medical history, which helps narrow down potential diseases. Modern medical technology offers high-resolution imaging and functional tests that accurately assess structural and functional abnormalities of the lungs.
Clinical assessment is the foundation of diagnosis. The doctor first conducts a detailed medical history inquiry, including the onset and severity changes of symptoms, and whether other symptoms such as hemoptysis or weight loss are present. For example, chronic cough with yellow-green sputum may indicate chronic obstructive pulmonary disease (COPD), while sudden onset of dyspnea may be related to pneumothorax.
During physical examination, a stethoscope is a key tool. The doctor carefully listens to alveolar breath sounds, wheezing, or crackles, which can suggest specific lesions. For instance, widespread wheezing may be seen in asthma, while localized crackles may reflect localized pulmonary edema or infection.
Imaging examinations are central to diagnosing pulmonary diseases. Chest X-rays can quickly reveal large abnormalities such as pneumonia, pulmonary atrophy, or tumors, while high-resolution computed tomography (HRCT) can precisely show alveolar structural changes, such as reticulations in interstitial pneumonia or emphysema. Pulmonary function tests (PFTs) directly evaluate ventilation function, with an FEV1/FVC ratio below 70% commonly seen in airway obstructive diseases.
Invasive procedures like bronchoscopy allow direct visualization of the airways and tissue sampling. Bronchoscopy combined with brushing or biopsy can diagnose lung cancer or infectious pathogens. Blood tests are used to assess inflammatory markers (such as C-reactive protein), blood gas analysis, or specific antibodies (such as tuberculin skin test).
Screening tools are often used in high-risk groups, such as long-term smokers undergoing low-dose CT scans for early detection of lung cancer. Questionnaire tools like the COPD Assessment Test (CAT) quantify symptom impact on quality of life, aiding in staging and treatment decisions. Biomarkers such as serum CYFRA21-1 levels can assist in monitoring lung cancer progression.
Differential diagnosis involves ruling out diseases with similar symptoms. For example, distinguishing asthma from cardiogenic dyspnea requires pulmonary function tests and electrocardiography. Dyspnea caused by pulmonary embolism versus heart failure should be differentiated through D-dimer blood tests and echocardiography.
Imaging differentiation is common between tumors and infections. Benign nodules and malignant tumors differ in shape and growth rate on CT images; radiologists evaluate risk using classification systems like LI-RADS. Chronic cough may be caused by gastroesophageal reflux or postnasal drip, which require 24-hour pH monitoring or nasal endoscopy for confirmation.
Early diagnosis can significantly improve prognosis. For example, in lung cancer, stage I patients have a 5-year survival rate of up to 70% after surgical resection, whereas late-stage metastatic patients have very limited treatment options. Early use of inhalers in COPD can slow lung function decline and prevent progression to respiratory failure.
Early identification of infectious pathogens can prevent complications. For instance, early treatment of tuberculosis with anti-tuberculosis drugs can lead to complete recovery, while delayed diagnosis may result in extensive pulmonary fibrosis or systemic dissemination. Regular health check-ups help high-risk groups detect abnormalities before symptoms appear, such as chronic cough or unexplained weight loss.
Chest X-ray can observe structural abnormalities such as effusion or nodules but cannot directly evaluate lung ventilation function. Combining pulmonary function tests provides information on airway obstruction and lung expansion capacity, helping to differentiate conditions like asthma and emphysema, ensuring comprehensive diagnosis.
In smokers, which test results may be affected by pack-years and require special attention?Long-term smokers often show decreased lung function indices, such as abnormal FEV1. Physicians consider pack-years and exposure duration to determine whether lung function decline is due to natural aging or disease, and use HRCT to exclude conditions like smoker's lung or fibrosis.
If a lung CT shows abnormal shadows but the patient is asymptomatic, is immediate treatment necessary?For asymptomatic patients with shadows on CT, physicians evaluate risk based on the shape, size, and growth rate of the shadows. If the nodule appears benign and is less than 8mm in diameter, regular follow-up may be recommended. If the shape is irregular or it enlarges rapidly, further biopsy or biomarker testing is necessary to exclude malignancy.
What preparations are needed before and after pulmonary function tests to ensure accurate results?Patients should avoid smoking and discontinue bronchodilators 24 hours before testing. During the test, full effort exhalation and repeated maneuvers are required to ensure consistency. Abnormal results may require blood tests or arterial blood gas analysis to assess gas exchange function.
When is bronchoscopy indicated? How are the risks of invasive procedures evaluated?Bronchoscopy is indicated when imaging reveals indeterminate shadows, recurrent infections, or suspected central lung cancer, to obtain tissue samples. Risks include laryngospasm or minor bleeding, but modern endoscopic techniques greatly reduce complications. For high-risk patients (such as those with coagulopathies), bleeding risk is assessed before proceeding.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
